1- our met endpoints argument has been verified by Kun Jin 2- our indication is in AD, where there are virtually no EFFECTIVE therapies vs Aldeyra`s indication which there 5 approved drugs that work.
You are actually probably not missing the point, you just can not acknowledge it for w.e reason.